Results 201 to 210 of about 2,491,702 (230)

Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis.

Clinical Dermatology, 2020
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, immunologically mediated cutaneous adverse reaction characterized by mucous membrane and epidermal detachment, with a mortality ranging from 15% to 25%.
M. Noe, R. Micheletti
semanticscholar   +1 more source

Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis

Acta bio-medica : Atenei Parmensis, 2019
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be considered a late-onset allergic reaction, can cause serious long-term sequelae. SJS/TEN are considered a spectrum of life-threatening adverse drug reactions. They have the
Liotti Lucia, Caimmi Silvia, Botta Paolo, Bernardini Roberto, Cardinale Fabio, Saretta Francesca, Mori Francesca, Crisafulli Giuseppe, Franceschini Fabrizio, Caffarelli Carlo   +9 more
semanticscholar   +1 more source

Incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) in France during 2003–16: a four‐source capture–recapture estimate

British Journal of Dermatology, 2020
Because of its rarity, the exact incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) is difficult to establish and closely depends on the size and type of the data source.
G. Chaby, C. Maldini, C. Haddad, B. Lebrun-Vignes, F. Hemery, S. Ingen‐Housz‐Oro, S. Gonzalez-Chiappe, P. Wolkenstein, O. Chosidow, O. Chosidow, A. Mahr, L. Fardet   +11 more
semanticscholar   +1 more source

Trends in mortality rates for Stevens–Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017

British Journal of Dermatology, 2019
Epidermal necrolysis (EN), the spectrum including Stevens-Johnson syndrome (SJS, detached-detachable body surface area [BSA]
T. Bettuzzi, L. Penso, N. Prost, F. Hemery, C. Hua, A. Colin, A. Mekontso-Dessap, L. Fardet, O. Chosidow, P. Wolkenstein, É. Sbidian, S. Ingen-Housz-Oro   +11 more
semanticscholar   +1 more source

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

Archives of Dermatology, 1993
S. Bastuji‐Garin, B. Rzany, R. Stern, N. Shear, L. Naldi, J. Roujeau   +5 more
semanticscholar   +1 more source

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Clinical reviews in allergy and immunology, 2018
M. Lerch, C. Mainetti, B. Terziroli Beretta‐Piccoli, T. Harr   +3 more
semanticscholar   +1 more source

Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review.

Journal of American Academy of Dermatology, 2015
T. Canavan, E. Mathes, I. Frieden, K. Shinkai   +3 more
semanticscholar   +1 more source

The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

Cell, 2020
Camila Rosat Consiglio, Nicola Cotugno, Christian Pou   +2 more
exaly  

Association between metabolic syndrome and periodontitis: The role of lipids, inflammatory cytokines, altered host response, and the microbiome

Periodontology 2000, 2021
Flavia Q Pirih, Neelima Singh, Jae M Shin   +2 more
exaly  

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

New England Journal of Medicine, 1996
J. Roujeau, J. Kelly, L. Naldi, B. Rzany, R. Stern, T. Anderson, A. Auquier, S. Bastuji‐Garin, O. Correia, F. Locati, M. Mockenhaupt, C. Paoletti, S. Shapiro, N. Shear, E. Schöpf, D. Kaufman   +15 more
semanticscholar   +1 more source